© 2001 by Oxford University Press
Journal of the National Cancer Institute, Vol. 93, No. 5, 388-395,
March 7, 2001
© 2001 Oxford University Press
REPORT |
Racial and Ethnic Differences in Advanced-Stage Prostate Cancer: the Prostate Cancer Outcomes Study
Affiliations of authors: R. M. Hoffman, Medicine Service, Department of Veterans Affairs Medical Center, Albuquerque, NM, and New Mexico Tumor Registry, University of New Mexico Health Sciences Center, Albuquerque; W. C. Hunt, New Mexico Tumor Registry, University of New Mexico Health Sciences Center; F. D. Gilliland, A. S. Hamilton, Department of Preventive Medicine, University of Southern California, Los Angeles; J. W. Eley, Georgia Center for Cancer Statistics, Rollins School of Public Health, Emory University, Atlanta, GA; L. C. Harlan, A. L. Potosky, Division of Cancer Control and Prevention, National Cancer Institute, Bethesda, MD; R. A. Stephenson, Utah Cancer Registry and Division of Urology, University of Utah School of Medicine, Salt Lake City; J. L. Stanford, Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, and Department of Epidemiology, University of Washington; P. C. Albertson, Division of Urology, University of Connecticut Health Sciences Center, Farmington.
Correspondence to: Richard M. Hoffman, M.D., M.P.H., General Internal Medicine 111GIM, Department of Veterans Affairs Medical Center, 1501 San Pedro Dr., S.E., Albuquerque, NM 87108 (e-mail: rhoffman{at}unm.edu).
Background: African-Americans have twice the risk of non-Hispanic whites for presenting with advanced-stage prostate cancer. To investigate the reasons for this difference, we evaluated the association between race/ethnicity and advanced-stage prostate cancer, adjusting for demographic, socioeconomic, clinical, and pathologic factors. Methods: A population-based cohort of 3173 men diagnosed with prostate cancer between October 1, 1994, and October 31, 1995, was analyzed. Medical record abstracts and self-administered survey questionnaires were used to obain information regarding race/ethnicity, age, marital status, insurance status, educational level, household income, employment status, comorbidity, urinary function, prostate-specific antigen level, tumor grade, and clinical stage. The odds ratio (OR) for advanced-stage prostate cancer was estimated with weighted logistic regression analysis. All P values were two-sided. Results: Clinically advanced-stage prostate cancers were detected more frequently in African-Americans (12.3%) and Hispanics (10.5%) than in non-Hispanic whites (6.3%). Socioeconomic, clinical, and pathologic factors each accounted for about 15% of the increased relative risk. After adjusting for all covariates, the risk remained statistically significantly increased for African-Americans (OR = 2.26; 95% confidence interval [CI] = 1.43 to 3.58) but not for Hispanics (OR = 1.23; 95% CI = 0.73 to 2.08). Conclusion: Traditional socioeconomic, clinical, and pathologic factors accounted for the increased relative risk for presenting with advanced-stage prostate cancer in Hispanic but not in African-American men.
This article has been cited by other articles:
![]() |
Y.-H. Shao, K. Demissie, W. Shih, A. R. Mehta, M. N. Stein, C. B. Roberts, R. S. DiPaola, and G. L. Lu-Yao Contemporary Risk Profile of Prostate Cancer in the United States J Natl Cancer Inst, September 16, 2009; 101(18): 1280 - 1283. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Keane, R. M. Tappen, C. L. Williams, and M. Rosselli Comparison of African American and Afro-Caribbean Older Adults' Self-Reported Health Status, Function, and Substance Use Journal of Black Psychology, February 1, 2009; 35(1): 44 - 62. [Abstract] [PDF] |
||||
![]() |
B. A. Jones, W.-L. Liu, A. B. Araujo, S. V. Kasl, S. N. Silvera, H. Soler-Vila, M. G.M. Curnen, and R. Dubrow Explaining the Race Difference in Prostate Cancer Stage at Diagnosis Cancer Epidemiol. Biomarkers Prev., October 1, 2008; 17(10): 2825 - 2834. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-C. Tan, C. Zeigler-Johnson, R. D. Mittal, A. Mandhani, B. Mital, T. R. Rebbeck, and H. Rennert Common 8q24 Sequence Variations Are Associated with Asian Indian Advanced Prostate Cancer Risk Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2431 - 2435. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Consedine, B. A. Adjei, P. M. Ramirez, and J. M. McKiernan An Object Lesson: Source Determines the Relations That Trait Anxiety, Prostate Cancer Worry, and Screening Fear Hold with Prostate Screening Frequency Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1631 - 1639. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Reynolds Prostate Cancer Screening in African American Men: Barriers and Methods for Improvement American Journal of Men's Health, June 1, 2008; 2(2): 172 - 177. [Abstract] [PDF] |
||||
![]() |
K. C. Torkko, A. van Bokhoven, P. Mai, J. Beuten, I. Balic, T. E. Byers, J. E. Hokanson, J. M. Norris, A. E. Baron, M. S. Lucia, et al. VDR and SRD5A2 Polymorphisms Combine to Increase Risk for Prostate Cancer in Both Non-Hispanic White and Hispanic White Men Clin. Cancer Res., May 15, 2008; 14(10): 3223 - 3229. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. A. Wallace, R. L. Prueitt, M. Yi, T. M. Howe, J. W. Gillespie, H. G. Yfantis, R. M. Stephens, N. E. Caporaso, C. A. Loffredo, and S. Ambs Tumor Immunobiological Differences in Prostate Cancer between African-American and European-American Men Cancer Res., February 1, 2008; 68(3): 927 - 936. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Hussain, P. Lenner, J. Sundquist, and K. Hemminki Influence of education level on cancer survival in Sweden Ann. Onc., January 1, 2008; 19(1): 156 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Robbins, D. Yin, and A. Parikh-Patel Differences in Prognostic Factors and Survival among White Men and Black Men with Prostate Cancer, California, 1995-2004 Am. J. Epidemiol., July 1, 2007; 166(1): 71 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Consedine, D. Horton, T. Ungar, A. K. Joe, P. Ramirez, and L. Borrell Fear, Knowledge, and Efficacy Beliefs Differentially Predict the Frequency of Digital Rectal Examination Versus Prostate Specific Antigen Screening in Ethnically Diverse Samples of Older Men American Journal of Men's Health, March 1, 2007; 1(1): 29 - 43. [Abstract] [PDF] |
||||
![]() |
C. A. Casiano, M. Mediavilla-Varela, and E. M. Tan Tumor-associated Antigen Arrays for the Serological Diagnosis of Cancer Mol. Cell. Proteomics, October 1, 2006; 5(10): 1745 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Cormier, Y. Xing, M. Ding, J. E. Lee, P. F. Mansfield, J. E. Gershenwald, M. I. Ross, and X. L. Du Ethnic differences among patients with cutaneous melanoma. Arch Intern Med, September 25, 2006; 166(17): 1907 - 1914. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. R. Rebbeck, C. H. Halbert, and P. Sankar Genetics, Epidemiology, and Cancer Disparities: Is it Black and White? J. Clin. Oncol., May 10, 2006; 24(14): 2164 - 2169. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. L. Kreps Communication and Racial Inequities in Health Care American Behavioral Scientist, February 1, 2006; 49(6): 760 - 774. [Abstract] [PDF] |
||||
![]() |
M. A. Sekeres, B. Peterson, R. K. Dodge, R. J. Mayer, J. O. Moore, E. J. Lee, J. Kolitz, M. R. Baer, C. A. Schiffer, A. J. Carroll, et al. Differences in prognostic factors and outcomes in African Americans and whites with acute myeloid leukemia Blood, June 1, 2004; 103(11): 4036 - 4042. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. A. Godley, A. P. Schenck, M. A. Amamoo, V. J. Schoenbach, S. Peacock, M. Manning, M. Symons, and J. A. Talcott Racial Differences in Mortality Among Medicare Recipients After Treatment for Localized Prostate Cancer J Natl Cancer Inst, November 19, 2003; 95(22): 1702 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Oakley-Girvan, L. N. Kolonel, R. P. Gallagher, A. H. Wu, A. Felberg, and A. S. Whittemore Stage at Diagnosis and Survival in a Multiethnic Cohort of Prostate Cancer Patients Am J Public Health, October 1, 2003; 93(10): 1753 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Ntais, A. Polycarpou, and J. P. A. Ioannidis Association of the CYP17 Gene Polymorphism with the Risk of Prostate Cancer: A Meta-Analysis Cancer Epidemiol. Biomarkers Prev., February 1, 2003; 12(2): 120 - 126. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Romualdi, D. Balding, I. S. Nasidze, G. Risch, M. Robichaux, S. T. Sherry, M. Stoneking, M. A. Batzer, and G. Barbujani Patterns of Human Diversity, within and among Continents, Inferred from Biallelic DNA Polymorphisms Genome Res., April 1, 2002; 12(4): 602 - 612. [Abstract] [Full Text] [PDF] |
||||














